Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open-label, randomized, placebo-controlled, Phase 2 study of Nutritional Protocol Including Nicotinamide Riboside Plus Standard of Care in patients with mild-to-moderate COVID-19

X
Trial Profile

Open-label, randomized, placebo-controlled, Phase 2 study of Nutritional Protocol Including Nicotinamide Riboside Plus Standard of Care in patients with mild-to-moderate COVID-19

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 13 Oct 2020

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nicotinamide riboside (Primary) ; Hydroxychloroquine
  • Indications COVID 2019 infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors ChromaDex
  • Most Recent Events

    • 13 Oct 2020 New trial record
    • 06 Oct 2020 According to a ChromaDex Media Release, the company look forward to the initiation of a Phase 3 study in the near future.
    • 06 Oct 2020 According to a ChromaDex Media Release, The research was conducted in partnership with ScandiBio Therapeutics,This study was led by Dr. Adil Mardinoglu and took place at the Umraniye Teaching and Research Hospital, University of Health Sciences, Istanbul, Turkey. ChromaDex provided NR (patented nicotinamide riboside) for the study, conducted through the ChromaDex External Research Program (CERP).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top